世界の放射線毒性（放射線障害、急性放射線症候群）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4903
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、放射線毒性（放射線障害、急性放射線症候群）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（輸血、抗生物質、その他）、用途別市場規模（病院、診療所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・放射線毒性（放射線障害、急性放射線症候群）の市場動向
・企業の競争状況、市場シェア
・放射線毒性（放射線障害、急性放射線症候群）の種類別市場規模（輸血、抗生物質、その他）
・放射線毒性（放射線障害、急性放射線症候群）の用途別市場規模（病院、診療所）
・放射線毒性（放射線障害、急性放射線症候群）の北米市場規模2016-2027（アメリカ、カナダ）
・放射線毒性（放射線障害、急性放射線症候群）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・放射線毒性（放射線障害、急性放射線症候群）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・放射線毒性（放射線障害、急性放射線症候群）の中南米市場規模2016-2027（メキシコ、ブラジル）
・放射線毒性（放射線障害、急性放射線症候群）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Aeolus Pharmaceuticals, Inc.、Atox Bio Ltd、BCN Biosciences LLC、Cellphire Inc、Daiichi Sankyo Co Ltd、FirstString Research Inc、RxBio Inc、Shuttle Pharmaceuticals LLC）
・結論

Market Analysis and Insights: Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market
The global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market.

Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Scope and Market Size
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Blood Transfusion
Antibiotic
Others

Segment by Application
Hospital
Clinic

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Aeolus Pharmaceuticals, Inc.
Atox Bio Ltd
BCN Biosciences LLC
Cellphire Inc
Daiichi Sankyo Co Ltd
FirstString Research Inc
RxBio Inc
Shuttle Pharmaceuticals LLC

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Blood Transfusion
1.2.3 Antibiotic
1.2.4 Others
1.3 Market by Application
1.3.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Perspective (2016-2027)
2.2 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Growth Trends by Regions
2.2.1 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Historic Market Share by Regions (2016-2021)
2.2.3 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Forecasted Market Size by Regions (2022-2027)
2.3 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Industry Dynamic
2.3.1 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Trends
2.3.2 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Drivers
2.3.3 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Challenges
2.3.4 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Players by Revenue
3.1.1 Global Top Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Players by Revenue (2016-2021)
3.1.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share by Players (2016-2021)
3.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue
3.4 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Concentration Ratio
3.4.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue in 2020
3.5 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Key Players Head office and Area Served
3.6 Key Players Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product Solution and Service
3.7 Date of Enter into Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Breakdown Data by Type
4.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Historic Market Size by Type (2016-2021)
4.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Forecasted Market Size by Type (2022-2027)

5 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Breakdown Data by Application
5.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Historic Market Size by Application (2016-2021)
5.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2016-2027)
6.2 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type
6.2.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2016-2021)
6.2.2 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2022-2027)
6.2.3 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2016-2027)
6.3 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application
6.3.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2016-2021)
6.3.2 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2022-2027)
6.3.3 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2016-2027)
6.4 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country
6.4.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2016-2021)
6.4.2 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2016-2027)
7.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type
7.2.1 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2016-2021)
7.2.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2022-2027)
7.2.3 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2016-2027)
7.3 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application
7.3.1 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2016-2021)
7.3.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2022-2027)
7.3.3 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2016-2027)
7.4 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country
7.4.1 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2016-2021)
7.4.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2016-2027)
8.2 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type
8.2.1 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2016-2027)
8.3 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application
8.3.1 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2016-2027)
8.4 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region
8.4.1 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2016-2027)
9.2 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type
9.2.1 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2016-2021)
9.2.2 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2022-2027)
9.2.3 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2016-2027)
9.3 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application
9.3.1 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2016-2021)
9.3.2 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2022-2027)
9.3.3 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2016-2027)
9.4 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country
9.4.1 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2016-2021)
9.4.2 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2016-2027)
10.2 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type
10.2.1 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2016-2027)
10.3 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application
10.3.1 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2016-2027)
10.4 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country
10.4.1 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Aeolus Pharmaceuticals, Inc.
11.1.1 Aeolus Pharmaceuticals, Inc. Company Details
11.1.2 Aeolus Pharmaceuticals, Inc. Business Overview
11.1.3 Aeolus Pharmaceuticals, Inc. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
11.1.4 Aeolus Pharmaceuticals, Inc. Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2016-2021)
11.1.5 Aeolus Pharmaceuticals, Inc. Recent Development
11.2 Atox Bio Ltd
11.2.1 Atox Bio Ltd Company Details
11.2.2 Atox Bio Ltd Business Overview
11.2.3 Atox Bio Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
11.2.4 Atox Bio Ltd Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2016-2021)
11.2.5 Atox Bio Ltd Recent Development
11.3 BCN Biosciences LLC
11.3.1 BCN Biosciences LLC Company Details
11.3.2 BCN Biosciences LLC Business Overview
11.3.3 BCN Biosciences LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
11.3.4 BCN Biosciences LLC Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2016-2021)
11.3.5 BCN Biosciences LLC Recent Development
11.4 Cellphire Inc
11.4.1 Cellphire Inc Company Details
11.4.2 Cellphire Inc Business Overview
11.4.3 Cellphire Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
11.4.4 Cellphire Inc Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2016-2021)
11.4.5 Cellphire Inc Recent Development
11.5 Daiichi Sankyo Co Ltd
11.5.1 Daiichi Sankyo Co Ltd Company Details
11.5.2 Daiichi Sankyo Co Ltd Business Overview
11.5.3 Daiichi Sankyo Co Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
11.5.4 Daiichi Sankyo Co Ltd Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2016-2021)
11.5.5 Daiichi Sankyo Co Ltd Recent Development
11.6 FirstString Research Inc
11.6.1 FirstString Research Inc Company Details
11.6.2 FirstString Research Inc Business Overview
11.6.3 FirstString Research Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
11.6.4 FirstString Research Inc Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2016-2021)
11.6.5 FirstString Research Inc Recent Development
11.7 RxBio Inc
11.7.1 RxBio Inc Company Details
11.7.2 RxBio Inc Business Overview
11.7.3 RxBio Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
11.7.4 RxBio Inc Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2016-2021)
11.7.5 RxBio Inc Recent Development
11.8 Shuttle Pharmaceuticals LLC
11.8.1 Shuttle Pharmaceuticals LLC Company Details
11.8.2 Shuttle Pharmaceuticals LLC Business Overview
11.8.3 Shuttle Pharmaceuticals LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
11.8.4 Shuttle Pharmaceuticals LLC Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2016-2021)
11.8.5 Shuttle Pharmaceuticals LLC Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Blood Transfusion
Table 3. Key Players of Antibiotic
Table 4. Key Players of Others
Table 5. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Regions (2016-2021)
Table 9. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Regions (2022-2027)
Table 11. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Trends
Table 12. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Drivers
Table 13. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Challenges
Table 14. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Restraints
Table 15. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Players (2016-2021)
Table 17. Global Top Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) as of 2020)
Table 18. Ranking of Global Top Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product Solution and Service
Table 22. Date of Enter into Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share by Type (2016-2021)
Table 26. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share by Application (2016-2021)
Table 30. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2022-2027) & (US$ Million)
Table 62. Aeolus Pharmaceuticals, Inc. Company Details
Table 63. Aeolus Pharmaceuticals, Inc. Business Overview
Table 64. Aeolus Pharmaceuticals, Inc. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
Table 65. Aeolus Pharmaceuticals, Inc. Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2016-2021) & (US$ Million)
Table 66. Aeolus Pharmaceuticals, Inc. Recent Development
Table 67. Atox Bio Ltd Company Details
Table 68. Atox Bio Ltd Business Overview
Table 69. Atox Bio Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
Table 70. Atox Bio Ltd Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2016-2021) & (US$ Million)
Table 71. Atox Bio Ltd Recent Development
Table 72. BCN Biosciences LLC Company Details
Table 73. BCN Biosciences LLC Business Overview
Table 74. BCN Biosciences LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
Table 75. BCN Biosciences LLC Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2016-2021) & (US$ Million)
Table 76. BCN Biosciences LLC Recent Development
Table 77. Cellphire Inc Company Details
Table 78. Cellphire Inc Business Overview
Table 79. Cellphire Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
Table 80. Cellphire Inc Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2016-2021) & (US$ Million)
Table 81. Cellphire Inc Recent Development
Table 82. Daiichi Sankyo Co Ltd Company Details
Table 83. Daiichi Sankyo Co Ltd Business Overview
Table 84. Daiichi Sankyo Co Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
Table 85. Daiichi Sankyo Co Ltd Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2016-2021) & (US$ Million)
Table 86. Daiichi Sankyo Co Ltd Recent Development
Table 87. FirstString Research Inc Company Details
Table 88. FirstString Research Inc Business Overview
Table 89. FirstString Research Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
Table 90. FirstString Research Inc Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2016-2021) & (US$ Million)
Table 91. FirstString Research Inc Recent Development
Table 92. RxBio Inc Company Details
Table 93. RxBio Inc Business Overview
Table 94. RxBio Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
Table 95. RxBio Inc Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2016-2021) & (US$ Million)
Table 96. RxBio Inc Recent Development
Table 97. Shuttle Pharmaceuticals LLC Company Details
Table 98. Shuttle Pharmaceuticals LLC Business Overview
Table 99. Shuttle Pharmaceuticals LLC Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2016-2021) & (US$ Million)
Table 100. Shuttle Pharmaceuticals LLC Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type: 2020 VS 2027
Figure 2. Blood Transfusion Features
Figure 3. Antibiotic Features
Figure 4. Others Features
Figure 5. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Report Years Considered
Figure 9. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Regions: 2020 VS 2027
Figure 12. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Regions (2022-2027)
Figure 13. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Players in 2020
Figure 14. Global Top Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue in 2020
Figure 16. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share by Type (2016-2021)
Figure 17. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share by Type (2022-2027)
Figure 18. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2016-2027)
Figure 20. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2016-2027)
Figure 21. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Country (2016-2027)
Figure 22. United States Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2016-2027)
Figure 26. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2016-2027)
Figure 27. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Country (2016-2027)
Figure 28. Germany Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Region (2016-2027)
Figure 38. China Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2016-2027)
Figure 46. Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2016-2027)
Figure 47. Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Country (2016-2027)
Figure 48. Mexico Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Country (2016-2027)
Figure 54. Turkey Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Aeolus Pharmaceuticals, Inc. Revenue Growth Rate in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2016-2021)
Figure 58. Atox Bio Ltd Revenue Growth Rate in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2016-2021)
Figure 59. BCN Biosciences LLC Revenue Growth Rate in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2016-2021)
Figure 60. Cellphire Inc Revenue Growth Rate in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2016-2021)
Figure 61. Daiichi Sankyo Co Ltd Revenue Growth Rate in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2016-2021)
Figure 62. FirstString Research Inc Revenue Growth Rate in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2016-2021)
Figure 63. RxBio Inc Revenue Growth Rate in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2016-2021)
Figure 64. Shuttle Pharmaceuticals LLC Revenue Growth Rate in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z11704 2021年4月 107Pages
当調査資料では、放射線毒性（放射線障害、急性放射線症候群）のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。放射線毒性（放射線障害、急性放射線症候群）の種類別市場規模（輸血、抗生物質、その他）、用途別市場規模（病院、診療所）、地域別市場規模（北米、アメリ...

世界の急性冠症候群（ACS）市場規模・現状・予測（2021年-2027年）

Global Acute Coronary Syndrome (ACS) Market Size, Status and Forecast 2021-2027
QYR2104Z0055 2021年4月 94Pages
QYResearch社発行の本調査資料では、急性冠症候群（ACS）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（単剤療法、併用療法）、用途別市場規模（病院、外来手術センター、診断センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界の重症急性呼吸器症候群（SARS）治療薬市場規模・現状・予測（2021年-2027年）

Global Severe Acute Respiratory Syndrome (SARS) Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z5204 2021年4月 93Pages
QYResearch社発行の本調査資料では、重症急性呼吸器症候群（SARS）治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（CEL-1000、D-3252、FDX-000、INO-4500、LCA-60、その他）、用途別市場規模（病院、診...

世界の急性骨髄性白血病（AML）市場規模・現状・予測（2021年-2027年）

Global Acute Myeloid Leukemia Market Size, Status and Forecast 2021-2027
QYR2104Z0072 2021年4月 91Pages
QYResearch社発行の本調査資料では、急性骨髄性白血病（AML）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、幹細胞移植、標的療法、その他）、用途別市場規模（病院、小売ドラッグストア、外来診療センター、腫瘍学センタ...

世界の急性反復発作（ARS）市場規模・現状・予測（2021年-2027年）

Global Acute Repetitive Seizures Market Size, Status and Forecast 2021-2027
QYR2104Z0078 2021年4月 96Pages
QYResearch社発行の本調査資料では、急性反復発作（ARS）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（USL-261、NRL-1、AZ-002、ダイアスタットレクタルジェル、その他）、用途別市場規模（病院、クリニック）、主要地域別市...

世界の短腸症候群（SBS）市場規模・現状・予測（2021年-2027年）

Global Short Bowel Syndrome (SBS) Market Size, Status and Forecast 2021-2027
QYR2104Z5225 2021年4月 96Pages
QYResearch社発行の本調査資料では、短腸症候群（SBS）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、非経口）、用途別市場規模（病院、診療所、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、...

世界の急性反復発作（ARS）市場規模・現状・予測（2021年-2027年）

世界の急性リンパ芽球性白血病（ALL）市場規模・現状・予測（2021年-2027年）

Global Acute Lymphoblastic Leukemia Market Size, Status and Forecast 2021-2027
QYR2104Z0065 2021年4月 131Pages
QYResearch社発行の本調査資料では、急性リンパ芽球性白血病（ALL）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、標的療法、放射線療法、幹細胞移植）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッ...

世界の急性間欠性ポルフィリン症（AIP）市場規模・現状・予測（2021年-2027年）

Global Acute Intermittent Porphyria Market Size, Status and Forecast 2021-2027
QYR2104Z0058 2021年4月 98Pages
QYResearch社発行の本調査資料では、急性間欠性ポルフィリン症（AIP）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ゴナドトロピン放出ホルモン類似体、予防的ヘマチン注入）、用途別市場規模（病院・クリニック、研究センター）、主要地域別市...

世界の急性間欠性ポルフィリン症（AIP）市場規模・現状・予測（2021年-2027年）

世界の放射線毒性（放射線障害、急性放射線症候群）市場 2021：企業別、地域別、種類・用途別 The Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market player…
世界の医療用放射線遮蔽市場規模・現状・予測（2021年-2027年） The growth of this market is mainly driven by factors such as growing incidences of cancer, increasing usage of nuclear medicine and radiation therapy for diagnosis and treatment of Cancer, increasing number of diagnostic imaging centers and installation bases of radiology equipment. Geographically,…
世界の放射線治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Radiation Therapy Market The global Radiation Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a…
世界の放射線皮膚炎治療市場規模・現状・予測（2021年-2027年） The pathophysiology of a radiation skin reaction is a combination of radiation injury and the subsequent inflammatory response and can occur at both the entrance and exit site of the irradiation. The major factor driving the radiation dermatitis treatment market is the increasing prevalence of cance…
世界の画像誘導放射線治療（IGRT）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Image-guided Radiation Therapy (IGRT) Market The global Image-guided Radiation Therapy (IGRT) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and…